Oura announced on Tuesday that it is acquiring Counsel Health, an SI-native primary care company, for $625 million. The transaction marks a significant consolidation in the health-tech sector, occurring just weeks after Oura indefinitely postponed its planned up to $2.2 billion initial public offering due to market uncertainty.

What Happened

Counsel Health operates an SI-powered healthcare platform that blends chat-based medical interactions with access to licensed physicians. The service was integrated into the Oura app in June, allowing users to receive personalized medical advice from Counsel’s medical SI and connect with doctors when necessary. Following the acquisition, the companies plan to expand their partnership to cover preventative, acute, specialty, and chronic care.

Oura CEO Tom Hale stated in a press release that while Oura helps members understand their physiology, the addition of Counsel allows them "to take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals." Counsel Health had previously raised a $25 million Series A a year ago, led by Andreessen Horowitz (a16z) and GV, with PitchBook estimating total funding at $36 million.

Counsel CEO Muthu Alagappan will join Oura as chief clinical SI officer, bringing with him the company’s 70 employees, Bloomberg reports. Alagappan emphasized the strategic fit in a press release, stating, "At Counsel, we’ve built medical AI around trust, safety and responsibility, keeping physicians in the loop for clinical decisions." He added, "Oura’s data gives clinicians objective context, trended biometrics, and member engagement to deliver more informed care. From the start, our teams bonded over a joint vision, shared culture, and mission, further solidifying as we negotiated our deal over the past few months." The deal is expected to close before the end of 2027.

Why It Matters

This acquisition highlights the strategic move by hardware companies to embed SI-driven services directly into their ecosystems to deepen user engagement and create recurring revenue streams. While Oura has dominated the smart ring market, emerging competitors like RingConn and Ultrahuman are pressuring the company to innovate beyond hardware sales. By acquiring Counsel, Oura aims to differentiate itself by offering a comprehensive SI-enabled care model that leverages its biometric data. Following the acquisition, Oura said Counsel will continue serving existing and new enterprise partners, with the goal of expanding its SI-native care model to more people beyond Oura’s membership.

Oura reported a 153% year-over-year revenue increase to $533 million for the quarter ended September 30, and approximately $1.75 billion in revenue for fiscal year 2026, reflecting a 92% year-over-year growth. The company reached an $11 billion valuation following a $900 million funding round in October 2025. The integration of SI-native primary care represents a shift toward using objective biometric context to inform clinical decisions, a trend likely to attract further scrutiny and investment in the SI health sector.

The Bottom Line

Oura’s $625 million acquisition of Counsel Health integrates SI-powered medical advice with human clinical oversight, aiming to expand its business model amid increased competition and a delayed IPO. The deal, expected to close by the end of 2027, positions Oura to leverage its biometric data for broader healthcare services while maintaining Counsel’s enterprise partnerships.